RIGL
RIGL
NASDAQ · Biotechnology

Rigel Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$46.64
+0.79 (+1.72%)
RIGL News1 articles
Pfizer Shares Edge Up as Rigel Completes Veppanu Licensing Deal
Pfizer shares edged up after Rigel completed a Veppanu licensing deal with Arvinas, providing a $35 million payment to Pfizer.
Earnings